Glutamine supplementation promotes heat shock protein 70 (HSP70) release in in vitro experimental models of sepsis.
During times of infection, HSP70 signals via cell surface ligands TLR2/4 to activate the inflammatory pathway of NF-κB, promoting the release of inflammatory mediators.
In an in vitro experimental model of sepsis, the HSP70 inhibitor KNK437 effectively blocks HSP70 release, diminishing the release of inflammatory mediators.
The addition of 2 mM of glutamine to a whole blood endotoxin model promotes the release of HSP70.
The effect of 2 mM glutamine on HSP70 release is lost after the addition of the HSP70 inhibitor KNK437 to an in vitro model of sepsis.